Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caduet and TLC for Metabolic Syndrome
NCT03504735Phase 4Completed
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- May 2005
- Primary completion
- Jan 2009
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of amlodipine in metabolic syndrome (2 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Resolution or improvement of metabolic syndrome at 12 months. Started May 2005; status: completed.
02
Drugs
amlodipine
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT03504735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03504735.